Navigation Links
Dyadic International and EnGen Bio to Present at Rodman & Renshaw Annual Global Investment Conference
Date:9/8/2010

JUPITER, Fla., Sept. 8 /PRNewswire-FirstCall/ -- Dyadic International, Inc. ("Dyadic") (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that its President and Chief Executive Officer, Mark Emalfarb, will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in New York City on Wednesday, September 15, 2010 at 8:20 a.m. on the Cleantech track.

(Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091214/DYADICLOGO)

Earlier in the week, on Monday, September 13th at 3:15 p.m. on the Healthcare track, the Chief Executive Officer of EnGen Bio, Inc., Mark R. Alfenito, Ph.D., will also be presenting. As previously announced, Dyadic and EnGen Bio have entered into a non-binding term sheet for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for biopharmaceutical drug applications.

The conference will include a series of one-on-one meetings with institutional investors. Investors interested in scheduling a meeting with Dyadic or in being added to Dyadic's email list may do so by contacting Heidi Zosiak at Dyadic at hzosiak@dyadic.com. Meetings may also be scheduled by contacting a Rodman & Renshaw representative directly.

Webcasts of both the Dyadic and EnGen Bio presentations will be held live and can be accessed at http://www.wsw.com/webcast/rrshq18/dyai.pk/ and http://www.wsw.com/webcast/rrshq18/engen/, respectively.

Following the live presentations, an audio a
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dyadic International Reports 2010 Second Quarter Financial Results
2. Dyadic International Raises Additional $1 Million to Complete $4 Million Convertible Note Offering
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
8. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
9. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
11. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... NEW YORK , May 17, 2013 /PRNewswire-iReach/ -- ... for Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life ... offering free PALS, BLS and ACLS online ... free manuals, people simply need to build an account ... review materials for these programs, United Medical Education is ...
(Date:5/17/2013)... , May 17, 2013  Serving a region of 650,000 ... , Caribbean Imaging and Radiation Therapy (CIRT, ... capabilities with the acquisition of an Elekta Versa HD™ system, ... HD offers clinicians the versatility to deliver conventional therapies to ... also enabling treatment of highly complex cancers that require extreme ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Data also showed differences in gastrointestinal and lipid ... among study population, PRINCETON, N.J., Feb. 6 ... announced results from the CASTLE study, in which,300 ... 100 mg of,ritonavir (REYATAZ/r) showed similar antiviral efficacy ...
... is,a life saving treatment option for people with ... far exceeds the supply. Each year,only about one-third ... receive one, and,some patients die while waiting. In ... how the current system for allocating donor,organs in ...
Cached Medicine Technology:CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 2CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 3CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 4CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 5CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 6Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 2Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 3
(Date:5/18/2013)... May 18, 2013 The Ayurvedic practitioner ... education institution in the West. Program is available in ... Ayurveda is a healing modality practiced for over 5,000 ... is considered that health begins when an individual lives ... of their individual needs. Ayurveda aims to heal an ...
(Date:5/18/2013)... Meadows, IL (PRWEB) May 18, 2013 ... urges Oregon Gov. John A. Kitzhaber, M.D., (D) to ... state law by prohibiting minors under the age of ... Oregon would become the third state in the nation ... already have enacted similar indoor tanning bans for minors. ...
(Date:5/18/2013)... 18, 2013 Spectrum Surgical Instruments ... May 17-22 in Austin, TX where thousands of ... and networking opportunities. , Spectrum Surgical/STERIS will ... scope repair capabilities and certified pre-owned equipment. ... information on proper instrument care of flexible endoscopes. ...
(Date:5/18/2013)... 2013 John Ravera, D.D.S., a Newport ... a new member to his dental team, Courtney Marino. , ... field for over 10 years. She received her degree from ... elected a member of Sigma Pi Alpha, a national honor ... working with patients of all ages, helping them understand the ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
Breaking Medicine News(10 mins):Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4
... as a second-line therapy had a significantly improved ... treated with topotecan (Hycamtin), according to research presented ... in Amsterdam, hosted by the International Association for ... showed significant improvements in tumor shrinkage, symptom control ...
... School of Public Health (HSPH), Massachusetts Institute of Technology ... Providence Health & Services have found that expanding low ... use, reduces financial strain on covered individuals, and improves ... study to evaluate the impact of insuring the uninsured ...
... teaches children about fitness and encourages them to live ... has statistical evidence that sports participation is also beneficial ... Keren Shahar, a Ph.D. student at Tel Aviv University,s ... supervision of Prof. Tammie Ronen and Prof. Michael Rosenbaum, ...
... WEDNESDAY, July 6 (HealthDay News) -- Move over, Lyme disease: ... of the country, and this one can kill. Known ... that attacks blood cells, causing flu-like symptoms that can make ... caused by bacteria, babesia microti parasites are carried by deer ...
... , WEDNESDAY, July 6 (HealthDay News) -- The next time you ... this: The high you get from eating all that fat may ... marijuana. The same mechanism that gives pot smokers the ... -- appears to help explain why people like fat so much, ...
... Amsterdam - 6 July, 2011 - Elsevier, a ... products and services, today announced the availability of ... SciVal Experts. The tool seamlessly links opportunities within ... profiles within SciVal Experts, automating the process of ...
Cached Medicine News:Health News:Medicaid increases use of health care, decreases financial strain, improves health 2Health News:Medicaid increases use of health care, decreases financial strain, improves health 3Health News:Leaving anger on the field 2Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3Health News:Binge Eating May Be a High All Its Own 2Health News:Binge Eating May Be a High All Its Own 3Health News:Elsevier matches funding opportunities to researcher expertise 2
... basic principle of a competitive enzyme immunoassay ... antigen and an labelled antigen bound to ... antiserum . The amount of enzyme conjugate ... antibody is inversely proportional to the concentration ...
... Progesterone (pregn-4-ene-3, 20-dione) is a C21 ... a double bond between C-4 and C-5 ... hormone which, in conjunction with estrogens, regulates,the ... it is particularly important in preparing the,endometrium ...
Microalbumin Turbidimetric Lipid / Protein Quantification 021-SDX001...
... known as Kininase II, is a dipeptidyl ... of at least 129,000. The structure of ... a polysaccharide residue and a zinc atom. ... types such as neuronal cells and renal ...
Medicine Products: